Arg-Gly-Asp-Ser

Catalog No.: 
ACHWUV517
CAS No.: 
91037-65-9
Molecular Formula: 
C15H27N7O8
Molecular Weight: 
433.42
Arg-Gly-Asp-Ser structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$66.00In stockInquiry
100mg98%$111.00In stockInquiry
250mg98%$240.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameArg-Gly-Asp-Ser
IUPAC Name(6S,12S,15S)-1,6-diamino-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid
MDL No.MFCD00076452
Molecular FormulaC15H27N7O8
Molecular Weight433.42
SMILESO=C(NCC(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(O)=O)=O)=O)[C@H](CCCNC(N)=N)N
InChI KeyNNRFRJQMBSBXGO-CIUDSAMLSA-N
SynonymRGDS | (S)-3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((R)-1-carboxy-2-hydroxy-ethyl)-succinamic acid | A916494 | C77102 | HY-12290 | Q27273860 | 3-[(S)-2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl
CAS No.91037-65-9
PubChem CID107775

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHWUV517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHWUV517 route product structure diagram
    ACHWUV51791037-65-9In Stock
Inquiry

2. ACHWUV517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHWUV517 route product structure diagram
    ACHWUV51791037-65-9In Stock
Inquiry

3. ACHWUV517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHWUV517 route product structure diagram
    ACHWUV51791037-65-9In Stock
Inquiry

Comments (0)